Palatin Technologies
PTN
#10101
Rank
NZ$41.58 M
Marketcap
NZ$24.42
Share price
-1.74%
Change (1 day)
1,394.89%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -NZ$8.39 Million

According to Palatin Technologies's latest financial reports the company's current earnings are NZ$8.84 Million. In 2024 the company made an earning of -NZ$44.73 Million, an increase over its 2023 earnings that were of -NZ$53.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$8.39 Million-81.25%
2024 -NZ$44.73 Million-16.9%
2023 -NZ$53.83 Million5.99%
2022 -NZ$50.79 Million-13.7%
2021 -NZ$58.85 Million33.25%
2020 -NZ$44.17 Million-172.11%
2019 NZ$61.24 M2352.33%
2018 NZ$2.49 M-94.13%
2017 NZ$42.55 M-154.92%
2016 -NZ$77.48 Million3.67%
2015 -NZ$74.74 Million878%
2014 -NZ$7.65 Million-72.64%
2013 -NZ$27.94 Million-33.11%
2012 -NZ$41.76 Million77.71%
2011 -NZ$23.5 Million
2003 -NZ$39.79 Million29.93%
2002 -NZ$30.63 Million36.18%
2001 -NZ$22.49 Million
1999 -NZ$18.67 Million6.04%
1998 -NZ$17.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$53.79 B-675,709.17%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$21.73 B-273,088.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
NZ$0.96 B-12,262.47%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-NZ$19.94 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.11 B-1,492.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.2 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$83.93 M-1,154.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-NZ$48.96 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-NZ$92.24 Million 1,058.48%๐Ÿ‡บ๐Ÿ‡ธ USA